Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 9,801–9,825 of 27,380 studies, newest first · page 393 of 1096.

September 2021 25

  1. 2021-09-14

    Exploring Memory Care Clinics in Minnesota: A Qualitative Analysis

    ✓ Peer-reviewed Health systems and care delivery Journal of geriatric psychiatry and neurology

    Key finding: We identified 6 themes regarding financial issues, staffing, appointment logistics, care provision during and after the memory evaluation as well as features of an ideal clinic. +4 more findings

  2. 2021-09-14

    Identification of Faecalibacterium prausnitzii strains for gut microbiome-based intervention in Alzheimer's-type dementia

    ✓ Peer-reviewed Disease mechanisms Cell reports. Medicine

    Key finding: We find that Faecalibacterium prausnitzii (F. prausnitzii) correlates with cognitive scores and decreases in the MCI group compared with the healthy group. +2 more findings

  3. 2021-09-14

    NAD+ supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING

    ✓ Peer-reviewed Inflammation and the immune system Proceedings of the National Academy of Sciences of the United States of America

    Key finding: Activation of cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING) are associated with DNA damage and senescence. cGAS-STING elevation was observed in the AD mice and normalized by NR treatment. +2 more findings

  4. 2021-09-14

    Intrinsic capacity and its associations with incident dependence and mortality in 10/66 Dementia Research Group studies in Latin America, India, and China: A population-based cohort study

    ✓ Peer-reviewed Disparities PLoS medicine

    Key finding: We aimed to inform planning by assessing intrinsic capacity prevalence, by characterising the target group, and by validating the general approach-testing hypotheses that DIC was consistently associated with higher risks of incident dependence and death. +3 more findings

  5. 2021-09-13

    Digital Endpoints: Definition, Benefits, and Current Barriers in Accelerating Development and Adoption

    ✓ Peer-reviewed Cognitive tests and assessment Digital Biomarkers

    Key finding: We conclude with an interdependent list of challenges that must be collaboratively addressed before these endpoints are widely adopted.

  6. 2021-09-13

    Effects of air pollution on dementia over Europe for present and future climate change scenarios

    ✓ Peer-reviewed Risk factors Environmental research

    Key finding: In this sense, this contribution evaluates the incidence of dementia (Alzheimer's disease, AD, and dementia from unspecified cause, DU) occurring in Europe associated with the exposure to air pollution (essentially NO2 and PM2.5) for the present climatic period (1991-2010) and for a future climate change scenario (RCP8.5, 2031-2050). +1 more finding

  7. 2021-09-13

    Understanding insomnia as systemic disease

    ✓ Peer-reviewed Risk factors Yeungnam University journal of medicine

    Key finding: However, a high proportion of patients with insomnia do not seek treatment, which results in high direct and indirect costs.

  8. 2021-09-13

    Epigenetic Age Acceleration and Cognitive Decline: A Twin Study

    ✓ Peer-reviewed Genetics The journals of gerontology. Series A, Biological sciences and medical sciences

    Key finding: In cross-sectional analyses at baseline, there was no association between DNAm age acceleration and cognitive function scores. +4 more findings

  9. 2021-09-13

    Associations of ophthalmic and systemic conditions with incident dementia in the UK Biobank

    ✓ Peer-reviewed Long-term cohort studies The British journal of ophthalmology

    Key finding: Our analysis included 12 364 adults aged 55-73 years from the UK Biobank cohort. +3 more findings

  10. 2021-09-12

    Ocular Neurodegenerative Diseases: Interconnection between Retina and Cortical Areas

    ✓ Peer-reviewed Brain scans and imaging Cells

    Key finding: Furthermore, several studies have shown that also ocular disorders present characteristics of neurodegenerative diseases and, on the other hand, CNS pathologies, i.e., Alzheimer disease (AD) and Parkinson disease (PD), which are causes of morbidity and mortality worldwide, show peculiar alterations at the ocular level.

  11. 2021-09-11

    Depression, cognitive reserve markers, and dementia risk in the general population

    ✓ Peer-reviewed Risk factors Aging & mental health

    Key finding: Baseline depression and low cognitive reserve significantly increased the risk of subsequent dementia at follow-up. +4 more findings

  12. 2021-09-11
  13. 2021-09-11

    Relationships between physical activity, sleep and cognitive function: A narrative review

    ✓ Peer-reviewed Prevention and risk Neuroscience and biobehavioral reviews

    Key finding: Other lifestyle factors, including sleep, are associated with cognitive function and dementia risk, and exercise is an effective therapeutic strategy for improving sleep. +3 more findings

  14. 2021-09-10

    Neurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors

    ✓ Peer-reviewed Vascular contributions Frontiers in aging neuroscience

    Key finding: VaD regroups heterogeneous neurological conditions in which the decline of cognitive functions, including executive functions, is associated with structural and functional alterations in the cerebral vasculature. +2 more findings

  15. 2021-09-10

    Ophthalmic Biomarkers for Alzheimer's Disease: A Review

    ✓ Peer-reviewed Brain scans and imaging Frontiers in aging neuroscience

    Key finding: Over recent years, significant advances have been made in using ocular biomarkers to diagnose various neurodegenerative diseases, including AD. +1 more finding

  16. 2021-09-10

    ApoE4 increases susceptibility to stress-induced age-dependent depression-like behavior and cognitive impairment

    ✓ Peer-reviewed Genetics Journal of psychiatric research

    Key finding: The results showed that 8-month apoE4-TR mice were more susceptible to the CUMS-induced depression-like behaviors and cognitive impairment than age-matched apoE3-TR mice.

  17. 2021-09-09

    Synaptic tau: A pathological or physiological phenomenon?

    ✓ Peer-reviewed Disease mechanisms Acta neuropathologica communications

    Key finding: Alongside synaptic pathology, recent data suggest that Tau has physiological roles in the pre- or post- synaptic compartments.

  18. 2021-09-09

    Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model

    ✓ Peer-reviewed Brain tissue and pathology Molecular neurodegeneration

    Key finding: Immunohistochemical analysis of M20/L85 mice revealed that pre-existing Aβ plaques exacerbate the spread and deposition of induced α-synuclein pathology. +3 more findings

  19. 2021-09-09

    Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: Forty-one participants (30 male, 11 female) with a mean (SD) age at death of 75.7 (10.6) years were included. +1 more finding

  20. 2021-09-09

    Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: Amyloid accumulation was evaluated in 236 individuals who underwent >1 amyloid PET scan.

  21. 2021-09-08

    Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease

    ✓ Peer-reviewed Hippocampus size on brain scans Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: These findings highlight the diagnostic and longitudinal monitoring potential of GFAP and p-tau for preclinical AD. +4 more findings

  22. 2021-09-08

    Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: A systematic review, meta-analysis and call for action

    ✓ Peer-reviewed Clinical safety EClinicalMedicine

    Key finding: Overall, mental and neurological disorders were associated with a significant high risk of infection (pre-existing mental: OR 1·67, 95% CI 1·12-2·49; and pre-existing neurological: 2·05, 1·58-2·67), illness severity (mental: pre-existing, 1·40, 1·25-1·57; sequelae, 4·85, 2·53-9·32; neurological: pre-existing, 1·43, 1·09-1·88; sequelae, 2·17, 1·45-3·24), and mortality (mental: pre-existing, 1·47, 1·26-1·72; neurological: pre-existing, 2·08, 1·61-2·69; sequelae, 2·03, 1·66-2·49) from COVID-19. +4 more findings

  23. 2021-09-08

    Machine-learning-based COVID-19 mortality prediction model and identification of patients at low and high risk of dying

    ✓ Peer-reviewed Digital health tools Critical care (London, England)

    Key finding: An accurate COVID-19 mortality prediction model among hospitalized patients based on the clinical features and comorbidities may play a beneficial role in the clinical setting to better management of patients with COVID-19. +2 more findings

  24. 2021-09-07

    Exercise Dose and Aerobic Fitness Response in Alzheimer's Dementia: Findings from the FIT-AD Trial

    ✓ Peer-reviewed Prevention trials International journal of sports medicine

    Key finding: The aerobic exercise group significantly increased peak oxygen consumption (1.28 ml/kg/min; p=0.03) in subgroup who achieved maximal criteria on cardiopulmonary exercise test. +2 more findings

  25. 2021-09-07

    Scoping review: the empowerment of Alzheimer's Disease caregivers with mHealth applications

    ✓ Peer-reviewed Cognitive tests and assessment NPJ digital medicine

    Key finding: The review revealed that mHealth applications for AD patients' caregivers are inadequate.

Browse the library by subject, with the full score breakdown →